Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-152-2
CAS number: 78-87-5
All animals survived until the end of the observation period.
Incoordination was observed in one mouse from the high-dose group. A
uniform drop in body temperature (approx. 2ºC) occurred 2 hrs
post-dosing in the high-dose animals. There was no statistically
significant increase in the frequencies of MN-PCE in groups treated with
PDC when compared to the negative controls. In contrast, a significant
increase in the frequency of MN-PCE was recorded in the positive control
group. The mean proportion of PCE among bone marrow erythrocytes
(200/animal) was unaffected by exposure to the test material while the
positive control treatment significantly reduced this value.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again